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Abstract
N-acylethanolamines (NAEs), such as anandamide (AEA), are a group of endogenous lipids derived from a fatty acid 
linked to ethanolamine and have a wide range of biological activities, including regulation of metabolism and food 
intake. We hypothesized that i) NAE plasma levels are associated with levels of total free fatty acids (FFAs) and their 
precursor fatty acid in fasting and non-fasting conditions and ii) moderate alcohol consumption alters non-fasting NAE 
levels. In a fasting and non-fasting study we sampled blood for measurements of specific NAEs and FFAs. In the fasting 
study blood was drawn after an overnight fast in 22 postmenopausal women. In the non-fasting study blood was 
sampled before and frequently after a standardized lunch with beer or alcohol-free beer in 19 premenopausal women. 
Fasting AEA levels correlated with total FFAs (r = 0.84; p < 0.001) and arachidonic acid levels (r = 0.42; p < 0.05). Similar 
results were observed for other NAEs with both total FFAs and their corresponding fatty acid precursors. In addition, 
AEA (r = 0.66; p < 0.01) and OEA levels (r = 0.49; p <0.02) positively related with BMI. Changes over time in non-fasting 
AEA levels were correlated with changes in total FFA levels, both after a lunch with beer (r = 0.80; 95% confidence 
interval: 0.54-0.92) and alcohol-free beer (r = 0.73; 0.41-0.89). Comparable correlations were found for other NAEs, 
without differences in correlations of each NAE between beer and alcohol free beer with lunch. In conclusion, i) in 
fasting and non-fasting states circulating anandamide and other N-acylethanolamines were associated with free fatty 
acid levels and ii) moderate alcohol consumption does not affect non-fasting NAE levels. This suggests that similar 
physiological stimuli cause the release of plasma N-acylethanolamines and free fatty acids in blood. The trials are 
registered at ClinicalTrials.gov numbers: NCT00524550 and NCT00652405.
Introduction
N-acylethanolamines (NAEs) are a group of lipid media-
tors, derived from a fatty acid precursor linked to an eth-
anolamine moiety. The best studied NAE is the
endocannabinoid arachidonoylethanolamide (anand-
amide; AEA). In addition to AEA, NAEs also comprise of
other non-endocannabinoids such as palmitoylethanol-
amide (PEA), oleoylethanolamide (OEA) and stearoyleth-
anolamide (SEA), for which palmitic acid, oleic acid and
stearic acid serve as their respective precursor fatty acids
(see Figure 1 for structures). NAEs have several biological
effects, including regulation of food intake and energy
metabolism [1,2].
Several studies have shown that dietary fatty acids
determine levels of corresponding NAEs in different tis-
sues, suggesting a link between availability of precursor
fatty acids and NAEs formation [3-5]. In obesity, a state
characterized by elevated circulating free fatty acids
(FFAs), levels of AEA are also increased [6,7]. Conversely,
when FFA levels decline after a meal, non-fasting levels of
AEA are concomitantly decreased in normal-weight sub-
jects [8]. This made us hypothesize that their release into
plasma is regulated by similar physiological stimuli and
that plasma NAE levels parallel those of total FFAs and
their precursor fatty acids.
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Page 2 of 6Secondly, since AEA and OEA are involved in the regu-
lation of appetite [9], we also wanted to study whether the
well-known appetite-inducing effects of acute alcohol
consumption [10] might be related to changes in NAEs.
Therefore, we investigated the correlation of different
NAEs with FFAs in both fasting and non-fasting condi-
tions and the effect of moderate alcohol consumption on
non-fasting NAE levels.
Subjects and Methods
Samples were analyzed from two studies (fasting and
non-fasting) conducted at TNO Quality of Life, Zeist, the
Netherlands. An independent centralized ethics commit-
tee (METOPP; Tilburg, the Netherlands) approved both
protocols. Studies are registered at Clinical trials.gov:
NCT00524550 and NCT00652405. Eligible women con-
sumed between 5 and 21 units of alcohol per week, were
apparently healthy, non-smokers and had no family his-
tory of alcoholism. They gave written informed consent.
For the fasting study we used samples from an interven-
tion study completed earlier [11]. At the first day of the
intervention subjects arrived at the premises after an
overnight fast when blood was drawn.
The non-fasting study was part of a randomized, open
label, crossover trial in which subjects consumed two
cans of beer (~13 g alcohol each) or two cans of alcohol-
free beer (<0.1 g alcohol) (both: Amstel, Amsterdam, the
Netherlands) daily for three weeks during dinner. Each
three-week intervention period was preceded by a one-
week wash-out. At the last day of each treatment, sub-
jects came to the premises for a standardized lunch (1978
kJ; 16.1% protein, 21.0% fat and 62.9% carbohydrate). The
two lunches were consumed around noon under similar
conditions, 28 days apart. Treatment order (beer vs. alco-
hol-free beer with lunch) was randomized according to
the intervention trial. A first can of study substance was
consumed one hour before the start of the lunch, a sec-
ond can during the lunch. Both cans were consumed
within 15 minutes. Blood was sampled before and at sev-
eral time points after lunch.
In both studies, venous blood was drawn in tubes con-
taining silica as clot activator for serum (FFA analysis) or
Potassium Ethylene Diamine Tetra Acid for plasma (NAE
analysis). To inactivate fatty acid amide hydrolase
(FAAH), phenylmethanesulphonyl fluoride (final concen-
tration: 100 μM) was added to the plasma samples. Total
FFA determinations in blood were performed using
Olympus analytical equipment and reagents. Plasma lev-
els of NAEs were determined using a LC-MS/MS tech-
nique [12]. Specific serum FFA were measured using a
high-resolution UHPLC-MS technique [13].
Pearson's coefficient of correlation was calculated to
assess correlations between fasting FFA and NAE. In the
non-fasting study variables at baseline (t = -60 min before
lunch) were compared between treatments with a mixed
analysis of variance model. For the correlation between
changes over time (non-fasting study), a Fisher's z trans-
formation was applied on individual correlations to cor-
rect for deviations from the normal distribution and 95%
confidence interval (CI) for each correlation coefficient
were calculated [14]. SAS statistical software package
(SAS version 9, SAS Institute, Cary, NC) was used to per-
form statistical analyses. Statistical significance was
defined as p < 0.05.
Results
The 22 postmenopausal women enrolled in the fasting
study had a mean BMI of 26.3 kg/m2 (range: 19.4-34.1)
and a mean age of 55.8 years (range: 51-61). See Table 1
for fasting characteristics. Fasting AEA levels correlated
positively with total FFA (r = 0.84, p < 0.001) and with
arachidonic acid levels (r = 0.42; p < 0.05). OEA, PEA and
SEA levels also positively correlated with serum fasting
total FFA levels (All r > 0.44; p < 0.05). Comparable corre-
Table 1: Fasting characteristics of the twenty-two 
postmenopausal women.
Variable
Glucose (mmol/L) 5.45 ± 0.11
Insulin (pmol/L) 51.9 ± 5.8
Triglycerides (mmol/L) 1.47 ± 0.13
Free fatty acids (mmol/L) 0.59 ± 0.06
Anandamide (nmol/L) 6.8 ± 0.70
Oleoylethanolamide (nmol/L) 43.8 ± 3.3
Palmitoylethanolamide (nmol/L) 40.0 ± 3.7
Stearoylethanolamide (nmol/L) 16.3 ± 1.9
Mean values and standard errors of the mean.
Figure 1 Structures of the N-acylethanolamines: anandamide 
(AEA), palmitoylethanolamide (PEA), oleoylethanolamide (OEA) 
and stearoylethanolamide (SEA).
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Page 3 of 6lations were observed between oleic acid and OEA (r =
0.71; p < 0.001), palmitic acid and PEA (r = 0.54; p < 0.01)
and stearic acid and SEA (r = 0.77; p < 0.0001) (Figure 2).
Furthermore, AEA (r = 0.66; p < 0.01) and OEA levels (r =
0.49; p < 0.02) were also positively related with BMI.
All 19 premenopausal (mean age 23.1 years; range 20-
32) women in the non-fasting study had a normal weight
(mean BMI: 22.2 kg/m2; range: 19.8-24.7). No differences
in FFA or NAE levels at baseline were observed between
treatments after the three week intervention periods (see
Table 2 for fasting characteristics). Curves for AEA, OEA,
PEA and total FFA after both meals are shown in Figure 3.
Non-fasting changes in total FFA were positively associ-
ated with changes in NAEs: (r = 0.73; 95% confidence
interval: 0.41-0.89) and (r = 0.80; 0.54-0.92) for AEA; (r =
0.89; 0.73-0.96) and (r = 0.91; 0.78-0.97) for OEA and (r =
0.77; 0.49-0.91) and (r = 0.76; 0.47-0.90) for PEA after a
meal either with nonalcoholic beer or beer respectively.
Correlations over time of each NAE with total FFAs did
not differ between lunches with or without alcohol con-
sumption. In a subgroup of six women, comparable coef-
ficients with NAEs and their specific fatty acids were
found for both lunches (data not shown).
Discussion
The primary findings of this study are i) all fasting and
non-fasting plasma NAEs investigated are positively asso-
ciated with both serum total FFAs and their specific fatty
acid precursor and ii) prolonged and acute moderate
alcohol consumption does not alter non-fasting NAE lev-
els. These findings imply that circulating NAEs are a
reflection of plasma FFA levels.
This suggests AEA levels to be altered in general under
conditions characterized by changes in circulating FFAs.
Indeed, increased levels of AEA are observed in obesity,
diabetes, and eating disorders such as anorexia and
binge-eating disorder [6,8,15]. Furthermore, increased
levels of circulating AEA, OEA and PEA were found in
patients with liver cirrhosis [16]. Besides the correlation
with fasting FFAs, we also observed a strong correlation
between AEA and OEA with BMI in postmenopausal
women. This is in line with previous work which
observed higher levels of AEA among obese postmeno-
Figure 2 Pearson correlations between plasma levels of several N-acylethanolamines and their corresponding serum levels of fatty acid in 
twenty-two postmenopausal women after an overnight fast.
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Page 4 of 6pausal women compared with normal-weight counter-
parts [6].
Although the release of NAEs into plasma may still be
biologically relevant, it remains to be determined of the
observed relation between FFA and NAE levels is also
causal. Perhaps, the increase in FFA levels is paralleled by
increased membrane phospholipid cleavage. The
increased levels of AEA and 2-arachidonoylglycerol (2-
AG), another arachidonic acid-derived endocannabi-
noid, have led to the concept of the 'overactivated' endo-
Table 2: Fasting characteristics after three weeks of consuming beer or alcohol-free beer.
Alcohol-free beer Beer P value
Glucose (mmol/L) 4.97 ± 0.07 5.09 ± 0.07 0.18
Insulin (pmol/L) 44.0 ± 9.2 37.1 ± 9.2 0.55
Triglycerides (mmol/L) 1.17 ± 0.07 1.08 ± 0.07 0.17
Free fatty acids (mmol/L) 0.39 ± 0.04 0.44 ± 0.04 0.18
Anandamide (nmol/L) 5.90 ± 0.39 5.98 ± 0.39 0.86
Oleoylethanolamide (nmol/L) 52.7 ± 6.5 54.4 ± 6.5 0.74
Palmitoylethanolamide (nmol/L) 53.9 ± 4.1 57.8 ± 4.1 0.23
Stearoylethanolamide (nmol/L) 15.1 ± 0.9 15.2 ± 0.9 0.98
Mean values and standard errors of the mean.
Figure 3 Means (±SEM) of serum free fatty acid (FFA) concentrations and plasma concentrations of anandamide (AEA), palmitoylethanol-
amide (PEA) and oleoylethanolamide (OEA) before and during three hours after a lunch with beer (black circles) or alcohol-free beer con-
sumption (open circles) in 19 normal-weight premenopausal women.
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Page 5 of 6cannabinoid system in obesity in which FAAH expression
is reduced [6,7,17]. However, our data suggest that
increased levels of endocannabinoids and other NAEs in
obesity could take place in parallel with increased FFA
concentrations and does not necessarily reflect a func-
tional change of the endocannabinoid system alone.
Only one other study investigated non-fasting AEA
concentrations in humans, without reporting results on
FFAs [8]. They found decreased AEA levels one hour
after a lunch. Possibly the physiological stimuli involved
in the decrease of FFA levels after consumption of a meal
also contribute to a reduced release of NAEs from mem-
brane phospholipids. However, a decreased activity of
enzymes involved in NAE synthesis such as N-acylphos-
phatidylethanolamine hydrolyzing phospholipase
(NAPE-PLD) or increased FAAH activity can not be
excluded.
To our best knowledge, this is the first human study in
which NAEs are reported after both prolonged and acute
moderate alcohol consumption. Acute alcohol consump-
tion is generally known to stimulate appetite [10]. In our
study, circulating non-fasting NAEs did not differ
between a lunch with or without alcohol consumption. It
thus seems unlikely that the acute appetite-inducing
effects of alcohol are caused by alterations in circulating
NAEs.
The observed correlations between NAEs and FFAs are
persistent for several NAEs in various populations (pre-
and postmenopausal women) and under different condi-
tions (fasting and non-fasting). However, some limita-
tions warrant consideration. It remains to be established
whether changes in plasma NAEs will also modify NAEs
in target tissues such as adipose tissue, brain, liver and
intestines as seen in animal studies [3] and to which
extend these changes affect physiology. The exact site of
NAE synthesis is unknown, but the liver, adipose tissue or
blood cells could contribute to the changes in NAE levels.
Furthermore, other regulators such as insulin may affect
NAE levels [18]. Finally, we did not measure 2-AG,
another important endocannabinoid, or other NAEs.
In conclusion, we provide evidence that in humans fast-
ing peripheral NAEs are positively correlated with both
serum total fasting FFA and their specific fatty acid pre-
cursor. Furthermore, we showed that non-fasting changes
over time in AEA and related NAEs are positively corre-
lated with non-fasting changes in free fatty acids, inde-
pendent of alcohol consumption. This suggests that
circulating N-acylethanolamines might be a reflection of
free fatty acids in blood. The biological significance of
these findings is still unknown and requires further inves-
tigation.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MJ designed study protocols, performed statistical analysis and drafted the
manuscript. MB developed the NAE analysis technique, participated in NAE
and FFA analysis and drafted the manuscript. KV developed the NAE analysis
technique was involved in NAE analyses. HH and RW participated in the design
and coordination of the study and significantly helped drafting the manu-
script. All authors read and approved the final manuscript.
Acknowledgements
We gratefully acknowledge the volunteers for participation; H Fick, D Rou-
wendaal, A Speulman, J Jansen, I Klöpping, I van den Assum, J Jacobs, E Busink, 
C Hoeflaken for practical work during the studies; J Catsburg, M Rondhuis, L 
Coulier, J Bezemer, R Ramaker and M Hekman for laboratory analyses; and E 
Dutman for data management; These studies were partially supported by the 
Dutch Foundation for Alcohol Research (SAR).
Author Details
1Business Unit Biosciences, TNO Quality of Life, Zeist, The Netherlands, 
2Division of Human Nutrition, Wageningen University, Wageningen, The 
Netherlands and 3Business Unit Quality & Safety, TNO Quality of Life, Zeist, The 
Netherlands
References
1. Lambert DM, Muccioli GG: Endocannabinoids and related N-
acylethanolamines in the control of appetite and energy metabolism: 
emergence of new molecular players.  Curr Opin Clin Nutr Metab Care 
2007, 10:735-744.
2. O'Sullivan SE: Cannabinoids go nuclear: evidence for activation of 
peroxisome proliferator-activated receptors.  Br J Pharmacol 2007, 
152:576-582.
3. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, 
Hansen SH, Hansen HS: Influence of dietary fatty acids on 
endocannabinoid and N-acylethanolamine levels in rat brain, liver and 
small intestine.  Biochim Biophys Acta 2008, 1781:200-212.
4. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V: 
Anandamide and diet: Inclusion of dietary arachidonate and 
docosahexaenoate leads to increased brain levels of the 
corresponding N-acylethanolamines in piglets.  Proc Natl Acad Sci USA 
2001, 98:6402-6406.
5. Matias I, Carta G, Murru E, Petrosino S, Banni S, Di Marzo V: Effect of 
polyunsaturated fatty acids on endocannabinoid and N-acyl-
ethanolamine levels in mouse adipocytes.  Biochim Biophys Acta 2008, 
1781:52-60.
6. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, 
Harvey-White J, Luft FC, Sharma AM, Jordan J: Activation of the 
Peripheral Endocannabinoid System in Human Obesity.  Diabetes 2005, 
54:2838-2843.
7. Engeli S, Jordan J: The endocannabinoid system: Body weight and 
metabolic regulation.  Clin Cornerstone 2006, 8:S24-S35.
8. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, 
Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, 
Monteleone P, Di Marzo V: Regulation, Function, and Dysregulation of 
Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in 
Obesity and Hyperglycemia.  J Clin Endocrinol Metab 2006, 91:3171-3180.
9. Hansen HS, Diep TA: N-acylethanolamines, anandamide and food 
intake.  Biochem Pharmacol 2009, 78:553-560.
10. Caton SJ, Ball M, Ahern A, Hetherington MM: Dose-dependent effects of 
alcohol on appetite and food intake.  Physiol Behav 2004, 81:51-58.
11. Joosten M, De Graaf C, Rietman A, Witkamp R, Hendriks H: Short-term 
oral exposure to white wine transiently lowers serum free fatty acids.  
Appetite  in press.
12. Balvers MGJ, Verhoeckx KCM, Witkamp RF: Development and validation 
of a quantitative method for the determination of 12 
endocannabinoids and related compounds in human plasma using 
liquid chromatography-tandem mass spectrometry.  J Chromatogr B 
Analyt Technol Biomed Life Sci 2009, 877:1583-1590.
13. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga 
PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, 
Received: 31 March 2010 Accepted: 14 June 2010 
Published: 14 June 2010
This article is available from: http://www.nutritionandmetabolism.com/content/7/1/49© 2010 Joosten et al; licensee BioMed Ce tral Ltd. is an Op  Access articl  distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutritio  & M tabolism 2010, 7:49
Joosten et al. Nutrition & Metabolism 2010, 7:49
http://www.nutritionandmetabolism.com/content/7/1/49
Page 6 of 6Cnubben N, Evelo C, van Ommen B, Kooistra T: Time-Resolved and 
Tissue-Specific Systems Analysis of the Pathogenesis of Insulin 
Resistance.  PLoS ONE 2010, 5:e8817.
14. Blom WA, Lluch A, Stafleu A, Vinoy S, Holst JJ, Schaafsma G, Hendriks HF: 
Effect of a high-protein breakfast on the postprandial ghrelin 
response.  Am J Clin Nutr 2006, 83:211-220.
15. Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V: 
Blood Levels of the Endocannabinoid Anandamide are Increased in 
Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia 
Nervosa.  Neuropsychopharmacology 2005, 30:1216-1221.
16. Caraceni P, Antonella V, Piscitelli F, Giannone F, Berzigotti A, Cescon M, 
Domenicali M, Petrosino S, Giampalma E, Riili A, Grazi G, Golfieri R, Zoli M, 
Bernardi M, Di Marzo V: Circulating and hepatic endocannabinoids and 
endocannabinoid-related molecules in patients with cirrhosis.  Liver 
International 2009:1-10.
17. Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, Pacher P, 
Schön MR, Jordan J, Stumvoll M: Dysregulation of the Peripheral and 
Adipose Tissue Endocannabinoid System in Human Abdominal 
Obesity.  Diabetes 2006, 55:3053-3060.
18. Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, Lundbom N, 
Piscitelli F, Westerbacka J, Soro-Paavonen A, Matias I, Van Gaal L, Taskinen 
MR: Role of insulin as a negative regulator of plasma endocannabinoid 
levels in obese and nonobese subjects.  Eur J Endocrinol 2009, 
161:715-722.
doi: 10.1186/1743-7075-7-49
Cite this article as: Joosten et al., Plasma anandamide and other N-acyletha-
nolamines are correlated with their corresponding free fatty acid levels 
under both fasting and non-fasting conditions in women Nutrition & Metabo-
lism 2010, 7:49
